Also:
- Share via
Northridge-based MiniMed Inc. said it expects U.S. sales of insulin pumps to increase 35% this quarter and the introduction of a new pump system to spur a “significant uptick” in growth this year. Its shares rose $3.50 to close at $36.50 on Nasdaq.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.